Glycolysis Pathway: The Essential Energy Source for Cells, Even in Low-Oxygen Conditions

1. What Is the Glycolysis Pathway?

Glycolysis is a fundamental metabolic pathway that oxidizes and breaks down glucose into pyruvate while yielding ATP and NADH molecules. Glycolysis occurs in the cellular cytoplasm, a semi-fluid matrix that fills the cell and surrounds the organelles. In addition to providing energy to cells, this process also produces substrates for subsequent metabolic pathways such as the Krebs cycle and anaerobic fermentation.

Glycolysis is a central metabolic pathway present in all cells, taking place in almost all living organisms, from bacteria to humans. Its versatility and efficiency in generating energy make it a vital process for cellular health and survival.

2. Steps of the Glycolysis Pathway

Glycolysis is a ten-step enzymatic reaction that converts glucose into pyruvate, generating energy in the form of ATP and NADH. This process can be divided into two phases: the energy investment phase and the energy payoff phase. The first to the fifth step is the energy investment phase. The energy payoff phase includes the sixth to the tenth step.

2.1 Energy Investment Phase

The energy investment phase includes steps 1-5. This phase prepares glucose for energy extraction. During this phase, glucose is phosphorylated and broken into two three-carbon molecules, with an initial investment of ATP.

Step 1. Phosphorylation of Glucose

The glucose first enters the cytoplasm of the cells and is phosphorylated to form glucose-6-phosphate (G6P) by the enzyme hexokinase (HK). In this process, one ATP molecule is consumed and a phosphate group is added to the glucose molecule. This step traps glucose in the cell.

Reaction: Glucose + ATP → Glucose-6-phosphate + ADP

Step 2. Isomerization of Glucose-6-Phosphate

In the second step, glucose-6-phosphate is converted into fructose-6-phosphate (F6P) by phosphoglucose isomerase (PGI). This reaction is reversible and mainly converts the six-membered ring structure of glucose into the five-membered ring structure of fructose.

Reaction: Glucose-6-phosphate ⇌ Fructose-6-phosphate

Step 3. Phosphorylation of Fructose-6-Phosphate

The third step is that fructose-6-phosphate is catalyzed by phosphofructokinase-1 (PFK-1) to fructose-1,6-bisphosphate (F-1,6-BP). This step consumes the second ATP molecule and is often considered the rate-limiting step of glycolysis ^[1,2].

Reaction: Fructose-6-phosphate + ATP → Fructose-1,6-bisphosphate + ADP

Step 4. Cleavage of Fructose-1,6-bisphosphate

In the fourth step, fructose-1,6-bisphosphate is broken down by aldolase into two three-carbon compounds: dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (G3P). These two molecules can be converted into each other.

Reaction: Fructose-1,6-bisphosphate ⇌ DHAP + G3P

Step 5. Isomerization of DHAP

The fifth step is that the DHAP is catalyzed by triose phosphate isomerase to glyceraldehyde-3-phosphate. At this point, all three-carbon compounds in the cell are glyceraldehyde-3-phosphate.

Reaction: DHAP ⇌ G3P

2.2 Energy Payoff Phase

The energy payoff phase includes steps 6-10. In this phase, energy is released from the three-carbon molecules, producing ATP and NADH. By the end of this phase, the energy harvested is greater than the initial ATP invested.

Step 6. Oxidation and Phosphorylation of G3P

In the sixth step, glyceraldehyde-3-phosphate undergoes oxidation and phosphorylation reaction under the catalysis of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to produce 1,3-diphosphoglycerate (1,3-BPG) ^[3]. At the same time, NAD+ is reduced to NADH and releases a hydrogen ion.

Reaction: G3P + NAD⁺ + Pi → 1,3-bisphosphoglycerate + NADH + H⁺

Step 7. Production of ATP

1,3-bisphosphoglycerate transfers a phosphate group to ADP, forming ATP and 3-phosphoglycerate (3-PG). This step is catalyzed by phosphoglycerate kinase (PGK). At this point, the cell has begun to obtain energy.

Reaction: 1,3-bisphosphoglycerate + ADP → 3-phosphoglycerate + ATP

Step 8. Isomerization of 3-Phosphoglycerate

3-phosphoglycerate is converted to 2-phosphoglycerate (2-PG) at the action of phosphoglycerate mutase. This reaction mainly changes the position of the phosphate group.

Reaction: 3-phosphoglycerate ⇌ 2-phosphoglycerate

Step 9. Dehydration of 2-Phosphoglycerate

At the catalysis of enolase, 2-phosphoglycerate loses a water molecule, forming phosphoenolpyruvate (PEP). This process increases the energy state of the molecule and prepares for subsequent ATP synthesis.

Reaction: 2-phosphoglycerate → PEP + H₂O

Step 10. Formation of Pyruvate and ATP

In the last step, phosphoenolpyruvate transfers a phosphate group to ADP under the catalysis of pyruvate kinase to generate pyruvate and the second ATP molecule. This reaction is irreversible and is a key regulatory point in glycolysis.

Reaction: PEP + ADP → Pyruvate + ATP

Overall, glycolysis products primarily include pyruvate, ATP, and NADH. Glycolysis produces a net gain of 2 ATP molecules per glucose molecule. This pathway is an important part of cellular energy metabolism and provides the basis for subsequent aerobic respiration or anaerobic metabolism.

The fate of these products is central to the cell’s metabolic strategy. Under aerobic conditions, pyruvate is transported into the mitochondria to be fully oxidized, maximizing ATP yield. However, in anaerobic conditions, pyruvate is converted to lactate to regenerate NAD⁺, allowing glycolysis to continue and provide ATP even in low-oxygen situations. Additionally, glycolytic intermediates serve as precursors for biosynthetic pathways, supporting cell growth and proliferation.

3. Key Enzymes and Regulation of Glycolysis

During glycolysis, key enzymes and regulatory mechanisms are crucial for the regulation of energy metabolism.

3.1 Key Enzymes in Glycolysis

During glycolysis, there are three key rate-limiting enzymes responsible for regulating the flow of metabolites and energy production within the cell, including hexokinase (HK), phosphofructokinase-1 (PFK-1), and pyruvate kinase (PK).

Hexokinase catalyzes the phosphorylation of glucose to glucose-6-phosphate, the first step in glycolysis. This reaction consumes one ATP molecule and is irreversible. This step is crucial as it traps glucose within the cell and marks the commitment to glycolysis. Hexokinase is widely present in muscle and brain tissues. Its activity is inhibited at high concentrations of glucose-6-phosphate, thereby preventing the overphosphorylation of glucose.

PFK-1 is the most important regulatory enzyme in the glycolysis process. It catalyzes the conversion of fructose-6-phosphate to fructose-1,6-bisphosphate, which also consumes one ATP molecule. This step is the main regulatory point of glycolysis and is affected by a variety of metabolites, such as AMP, ATP, and citric acid, which regulate the catalytic activity of PFK-1. High concentrations of ATP inhibit the activity of PFK-1, while AMP activates its activity, indicating a change in the cellular energy state.

Pyruvate kinase catalyzes the conversion of phosphoenolpyruvate to pyruvate and generates ATP. This reaction is also irreversible, marking the end of glycolysis. The activity of pyruvate kinase is also regulated by a variety of metabolites. For example, an ATP-rich environment inhibits the activity of pyruvate kinase, whereas fructose-1,6-bisphosphate acting as an allosteric activator stimulates its activity. This regulatory mechanism ensures that glycolysis is tightly controlled according to the energy demands of the cell.

3.2 Regulation of Glycolysis

The regulation of glycolysis is a complex process involving the interaction of multiple signaling pathways, the coordinated action of which ensures that the energy needs of cells are met in different physiological and pathological states.

3.2.1 PI3K/Akt Signaling Pathway

Upon growth factors binding to receptor tyrosine kinases (RTKs), the PI3K/Akt is activated to promote cellular glucose uptake and glycolysis by upregulating glucose transporters such as GLUT1 and GLUT4 ^[4,5]. Akt activation stimulates the translocation of these transporters to the cell membrane, thereby increasing glucose uptake by the cell.

The PI3K/Akt pathway also enhances the glycolysis process by regulating the expression of glycolysis-related enzymes. Akt activation stimulates the HK activity, ensuring that glucose continues through the glycolytic pathway, thus promoting both energy production and cell growth ^[6,7].

3.2.2 Insulin Signaling Pathway

Glycolysis is regulated by a critical bifunctional enzyme, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 (PFKFB1) ^[8]. Insulin dephosphorylates the phosphorylated form of PFKFB1 (pPFKFB1), activating its kinase activity and thereby enhancing glycolysis ^[9].

Insulin also stimulates the translocation of glucose transporters such as GLUT4 on the cell membrane, enabling cells to absorb glucose more efficiently, thus providing sufficient substrates for glycolysis ^[10].

3.2.3 AMP-Activated Protein Kinase (AMPK) Signaling Pathway

AMPK is a key energy sensor activated mainly when cellular energy (ATP) levels are low. When AMP or ADP levels rise, AMPK is activated and stimulates glycolysis by upregulating glucose uptake and glycolytic enzymes like PFK-1 ^[11]. For example, in cardiomyocytes, AMPK activation promotes enhanced glycolysis, helping the heart to provide sufficient ATP when energy demands increase ^[12].

3.2.4 Hypoxia-Inducible Factor (HIF) Pathway

HIF-1 is a transcription factor activated under primarily under hypoxic conditions, regulating cellular metabolic processes, especially glycolysis. Under conditions of hypoxia, HIF-1α is stabilized and dimerizes with HIF-1β to form an active HIF complex, which binds to specific DNA sequences and activates transcription of the genes encoding glycolytic enzymes, including hexokinase, PFK-1, and lactate dehydrogenase ^[13,14].

4. Glycolysis Dysregulation and Diseases

Glycolysis dysregulation is closely related to the occurrence of many diseases, especially in cancer, metabolic diseases, and neurodegenerative diseases.

4.1 Glycolysis and Cancer

Upregulation of glycolysis is considered an important feature of cancer, which confers cancerous cells a significant and identifiable growth advantage. Tumor cells often exhibit the "Warburg Effect", that is, they preferentially perform glycolysis even under aerobic conditions to quickly produce energy and metabolic intermediates to support their rapid proliferation. The key to this process is the regulation of enzymes such as hexokinase and lactate dehydrogenase, which are often abnormally expressed in tumor cells.

Alterations in glycolysis not only provide energy but also produce many metabolites that can promote tumor growth and metastasis. These metabolites include lactate, which can change the tumor microenvironment and promote tumor cell invasiveness and immune escape.

4.2 Glycolysis and Metabolic Diseases

Some inherited glycolysis defects can lead to red blood cell metabolic disorders, which usually manifest as hemolytic anemia or metabolic myopathy. These diseases are caused by the absence or dysfunction of key enzymes in the glycolysis process, which makes red blood cells fail to metabolize glucose normally, thus affecting their survival and function. For instance, hexokinase, glucose-6-phosphate isomerase, and pyruvate kinase deficiencies cause severe hemolytic anemia.

4.3 Glycolysis and Neurodegenerative Diseases

Recent studies have shown that glycolysis dysfunction is associated with a variety of neurodegenerative diseases such as Parkinson's disease and Huntington's disease. Normal glycolysis is essential for maintaining neuronal activity. Studies have found that in patients with these neurodegenerative diseases, the activity of key enzymes in glycolysis is reduced, the energy metabolism of neurons is affected, and cell function is impaired and death occurs ^[15,16].

Conclusion

The glycolysis pathway is an essential and adaptable mechanism that sustains cellular energy needs across varying conditions. Glycolysis is fundamental not only in energy production but also in supplying precursors for biosynthetic pathways. The pathway’s regulation through specific enzymes allows cells to respond to their energy status and environmental oxygen levels, balancing glycolysis with other metabolic processes. Abnormalities in glycolysis are linked to various health conditions, including cancer and metabolic diseases, underscoring the importance of this pathway in both normal physiology and disease states.

CUSABIO can provide various enzymes related to glycolysis only for research.

References

[1] L. Tanner, A. Goglia, et al. Four key steps control glycolytic flux in mammalian cells [J]. Cell Systems, vol. 7, no. 1, p. 49-62.e8, 2018.

[2] S. Inamdar. Rescue of dendritic cells from glycolysis inhibition improves cancer immunotherapy in mice [J]. Nature Communications, vol. 14, no. 1, 2023.

[3] A. Shestov, X. Liu, et al. Quantitative determinants of aerobic glycolysis identify flux through the enzyme gapdh as a limiting step [J]. Elife, vol. 3, 2014.

[4] Taha C, Liu Z, Jin J, Al-Hasani H, Sonenberg N, Klip A. Opposite translational control of GLUT1 and GLUT4 glucose transporter mRNAs in response to insulin. Role of mammalian target of rapamycin, protein kinase b, and phosphatidylinositol 3-kinase in GLUT1 mRNA translation [J]. J Biol Chem. 1999;274:33085–91.

[5] Barthel A, Okino ST, et al. Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1 [J]. J Biol Chem. 1999;274:20281–6.

[6] Gottlob K, Majewski N, et al. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase [J]. Genes Dev. 2001;15:1406–18.

[7] John S, Weiss JN, Ribalet B. Subcellular localization of hexokinases I and II directs the metabolic fate of glucose [J]. PLoS ONE. 2011;6:e17674.

[8] Okar DA, Lange AJ, et al. (2001) PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci 26: 30–35.

[9] Probst I, Unthan-Fechner K (1985) Activation of glycolysis by insulin with a sequential increase of the 6-phosphofructo-2-kinase activity, fructose-2,6-bisphosphate level and pyruvate kinase activity in cultured rat hepatocytes. Eur J Biochem/FEBS 153: 347–353.

[10] Luc Bertrand, Sandrine Horman, et al. Insulin signalling in the heart [J]. Cardiovascular Research, Volume 79, Issue 2, 15 July 2008, Pages 238–248.

[11] Arad M, Seidman CE, Seidman JG. AMP-activated protein kinase in the heart: role during health and disease [J]. Circ Res. 2007 Mar 2;100(4):474-88.

[12] Jeon, SM. Regulation and function of AMPK in physiology and diseases [J]. Exp Mol Med 48, e245 (2016).

[13] Hidefumi Kojima, Ayano Kobayashi, et al. Differentiation Stage-Specific Requirement in Hypoxia-Inducible Factor-1α–Regulated Glycolytic Pathway during Murine B Cell Development in Bone Marrow [J]. J Immunol 1 January 2010; 184 (1): 154–163.

[14] Kierans SJ, Taylor CT. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology [J]. J Physiol. 2021 Jan;599(1):23-37.

[15] Zhang, X., Alshakhshir, N., & Zhao, L. (2021). Glycolytic Metabolism, Brain Resilience, and Alzheimer’s Disease [J]. Frontiers in Neuroscience, 15, 662242.

[16] Bell, S. M., Burgess, T., Lee, J., Blackburn, D. J., Allen, S. P., & Mortiboys, H. (2019). Peripheral Glycolysis in Neurodegenerative Diseases [J]. International Journal of Molecular Sciences, 21(23), 8924.